Bayer in Berkeley

New cell and gene therapies are showing great promise to transform treatments for cancer, blood disorders, cardiovascular disease, Parkinson’s disease, Alzheimer’s and more. Around the world, patients are waiting for these healthcare innovations to make it to market. That’s where the Biotech@Bayer team comes in. At our 46-acre campus in Berkeley, California, we're developing and launching advanced medicines that target illnesses at their source, creating the manufacturing capacity needed to take these discoveries out of the lab and to patients at scale. We're building on more than 30 years of history developing and serving as the global manufacturing center for Bayer's portfolio of hemophilia biotherapies. For more information, go to www.bayer.com/berkeley.